Display options
Share it on

Physiol Rep. 2015 Nov;3(11). doi: 10.14814/phy2.12584.

Chronic exposure to low doses of lipopolysaccharide and high-fat feeding increases body mass without affecting glucose tolerance in female rats.

Physiological reports

Anete Dudele, Christina W Fischer, Betina Elfving, Gregers Wegener, Tobias Wang, Sten Lund

Affiliations

  1. Section for Zoophysiology, Department of Bioscience, Aarhus University, Aarhus, Denmark [email protected].
  2. Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Risskov, Denmark.
  3. Section for Zoophysiology, Department of Bioscience, Aarhus University, Aarhus, Denmark.
  4. Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.

PMID: 26537342 PMCID: PMC4673625 DOI: 10.14814/phy2.12584

Abstract

Obesity-related inflammation may have a causal role in the development of diabetes and insulin resistance, and studies using animal models of chronic experimental endotoxemia have shown the link. However, many studies use only males, and much less is known about the role of obesity-related inflammation in females. Therefore, we addressed how experimentally induced chronic inflammation affects body mass, energy intake, and glucose metabolism in female rats. Adult female Sprague Dawley rats were instrumented with slow release pellets that delivered a constant daily dose of 53 or 207 μg of lipopolysaccharide (LPS) per rat for 60 days. Control rats were instrumented with vehicle pellets. Due to inflammatory nature of high-fat diet (HFD) half of the rats received HFD (60% of calories from lard), while the other half remained on control diet to detect possible interactions between two modes of induced inflammation. Our results showed that chronic LPS administration increased female rat body mass and calorie intake in a dose-dependent manner, and that HFD further exacerbated these effects. Despite these effects, no effects of LPS and HFD were evident on female rat glucose metabolism. Only LPS elevated expression of inflammatory markers in the hypothalamus. To conclude, female rats respond to experimentally induced chronic inflammation by increasing body mass, but do not develop glucose intolerance in the given period of time.

© 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.

Keywords: Chronic endotoxemia; female rats; glucose tolerance; high‐fat diet

References

  1. Science. 1993 Jan 1;259(5091):87-91 - PubMed
  2. Am J Clin Nutr. 2008 May;87(5):1219-23 - PubMed
  3. Am J Physiol Endocrinol Metab. 2009 May;296(5):E1003-12 - PubMed
  4. J Endotoxin Res. 2001;7(3):167-202 - PubMed
  5. Physiol Behav. 2005 Jan 31;84(1):165-73 - PubMed
  6. Cardiovasc Res. 2008 Aug 1;79(3):360-76 - PubMed
  7. Diabetes. 2010 Jan;59(1):172-81 - PubMed
  8. Circulation. 1999 Jan 19;99(2):237-42 - PubMed
  9. J Clin Invest. 2006 Nov;116(11):3015-25 - PubMed
  10. Gastroenterology. 2015 May;148(6):1219-33 - PubMed
  11. Cytokine. 2008 May;42(2):145-51 - PubMed
  12. J Nutr. 1972 Aug;102(8):1079-84 - PubMed
  13. Synapse. 2008 Apr;62(4):302-9 - PubMed
  14. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1323-32 - PubMed
  15. Cell. 1998 Feb 20;92(4):573-85 - PubMed
  16. Dis Model Mech. 2012 Sep;5(5):649-59 - PubMed
  17. Nutr Res Rev. 2010 Dec;23(2):270-99 - PubMed
  18. Ann N Y Acad Sci. 1993 Jun 14;683:82-90 - PubMed
  19. Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1269-76 - PubMed
  20. J Clin Invest. 2012 Jan;122(1):153-62 - PubMed
  21. Diabetes. 2004 Dec;53 Suppl 3:S215-9 - PubMed
  22. Pharmacol Res. 2008 Jan;57(1):6-18 - PubMed
  23. Endocrinology. 2009 Nov;150(11):4901-10 - PubMed
  24. Acta Neuropsychiatr. 2015 Jun;27(3):189-94 - PubMed
  25. Endocrinology. 2005 Oct;146(10):4192-9 - PubMed
  26. Diabetes Res Clin Pract. 2005 Jul;69(1):29-35 - PubMed
  27. Endocr Rev. 2006 Dec;27(7):750-61 - PubMed
  28. Diabetes. 2008 Jun;57(6):1470-81 - PubMed
  29. Exp Gerontol. 2003 Oct;38(10):1119-27 - PubMed
  30. Physiol Behav. 1988;42(3):287-91 - PubMed
  31. Physiol Behav. 2004 Sep 15;82(2-3):251-61 - PubMed
  32. Obes Res. 2002 Sep;10(9):956-63 - PubMed
  33. J Neuroendocrinol. 2013 May;25(5):433-45 - PubMed
  34. Diabetologia. 2011 Dec;54(12):3003-6 - PubMed
  35. Brain Behav Immun. 2009 Oct;23(7):926-30 - PubMed
  36. J Clin Endocrinol Metab. 2000 Oct;85(10):3770-8 - PubMed
  37. J Zhejiang Univ Sci B. 2005 Nov;6(11):1045-56 - PubMed
  38. Synapse. 2008 Sep;62(9):662-70 - PubMed
  39. JAMA. 2001 Jul 18;286(3):327-34 - PubMed
  40. Cardiovasc Pathol. 2009 Jan-Feb;18(1):1-10 - PubMed
  41. Eur J Nutr. 2000 Oct;39(5):229-34 - PubMed
  42. Bone. 2006 Mar;38(3):378-86 - PubMed
  43. Cancer Res. 2004 Aug 1;64(15):5245-50 - PubMed
  44. Biochimie. 2011 Jan;93(1):39-45 - PubMed
  45. Ann N Y Acad Sci. 1998 May 1;840:586-90 - PubMed
  46. Nutr Clin Pract. 2012 Apr;27(2):215-25 - PubMed
  47. Am J Reprod Immunol. 2004 Jul;52(1):19-26 - PubMed
  48. Diabetologia. 2001 Jan;44(1):3-15 - PubMed
  49. Diabetes. 2007 Jul;56(7):1761-72 - PubMed
  50. FEBS Lett. 2008 Jan 9;582(1):97-105 - PubMed

Publication Types